Top 10 Companies in the Pharmaceutical Active and Intelligent Packaging Market (2026): Market Leaders Powering Global Innovation

MARKET INSIGHTS

Global Pharmaceutical Active and Intelligent Packaging market size was valued at USD 51.24 billion in 2025 and is projected to reach USD 93.67 billion by 2034, exhibiting a compound annual growth rate of 9.00 % during the forecast period.

Pharmaceutical active and intelligent packaging are advanced systems designed to extend shelf life, monitor product quality, and enhance safety. Active packaging interacts with the contents by incorporating components such as oxygen scavengers, moisture absorbers, and antimicrobial agents to actively maintain the internal environment. Intelligent packaging, however, focuses on monitoring and communication, using technologies such as time‑temperature indicators, RFID tags, and freshness sensors to provide data on the product’s condition and history throughout the supply chain.

The market growth is primarily driven by the stringent regulatory requirements for drug safety, the rising incidence of counterfeit pharmaceuticals, and the expanding market for biologics and temperature‑sensitive drugs that demand sophisticated packaging solutions. Recent advancements, such as the integration of NFC technology for patient engagement and smart labels that track dosage compliance, are further accelerating adoption. Key players like Amcor PLC and Gerresheimer AG are actively expanding their portfolios through innovation and strategic partnerships to capitalize on this growing demand.

Pharmaceutical Active and Intelligent Packaging Market – View in Detailed Research Report

Top 10 Companies in the Market

1. Amcor PLC – Zurich, Switzerland
   Key Offering: Comprehensive range of pharmaceutical packaging solutions, including moisture‑barrier films, blister packaging, and smart monitoring systems.
   Amcor has positioned itself at the forefront of active packaging by integrating phase‑change materials and antimicrobial agents directly into polymer matrices, thereby extending product shelf life for temperature‑sensitive biologics. The company’s recent partnership with a leading biologics manufacturer has accelerated the deployment of active blister packs equipped with real‑time temperature sensors.
   Sustainability Initiative: Amcor is pursuing a circular economy model, targeting 100 % recyclable packaging by 2030 and investing in biodegradable film technologies.
   Highlights:

   • Global manufacturing footprint across 20 countries
   • Robust R&D pipeline focused on smart label integration
   • Strategic acquisitions in the NFC and IoT space

2. Gerresheimer AG – Germany
   Key Offering: Glass and plastic containers with integrated intelligent features for drug integrity.
   Gerresheimer’s glass vials now embed RFID chips that enable end‑to‑end serialization, ensuring compliance with DSCSA and EU FMD mandates. The company’s recent launch of a smart blister pack that couples humidity control with a QR‑code authentication system exemplifies its commitment to anti‑counterfeiting solutions.
   Sustainability Initiative: Gerresheimer has committed to reducing its carbon footprint by 30 % by 2030 through energy‑efficient manufacturing and the use of recycled glass.
   Highlights:

   • Dedicated cleanroom facilities for sterile packaging
   • Advanced collaboration with pharmaceutical contract manufacturers
   • Strong presence in the EU and North America markets

3. AptarGroup, Inc. – United States
   Key Offering: Active dispensing systems, including drug delivery devices and controlled‑release mechanisms.
   Aptar’s recent innovation is a blister pack that incorporates a micro‑chip capable of transmitting dosage data to a patient’s mobile device, bridging the gap between packaging and digital health platforms.
   Sustainability Initiative: Aptar is exploring biodegradable blister materials and has set a target to phase out single‑use plastics from its packaging line by 2035.
   Highlights:

   • Leading position in the oral drug segment
   • Partnerships with major pharmaceutical companies for patient‑centric packaging
   • Investment in AI‑driven packaging design tools

4. Sealed Air Corporation – United States
   Key Offering: Active packaging materials engineered for temperature‑sensitive pharmaceuticals.
   Sealed Air’s recent product launch, a multi‑layer film with integrated phase‑change material, offers passive cold‑chain protection for biologics during transport and storage.
   Sustainability Initiative: The company has pledged to reduce greenhouse gas emissions by 25 % by 2030 and to increase the recyclability of its packaging films.
   Highlights:

   • Global manufacturing hubs in North America, Europe, and Asia‑Pacific
   • Strong focus on barrier technology for inhalation products
   • Collaborations with logistics firms to optimize cold‑chain routes

5. Sonoco Products Company – United States
   Key Offering: Temperature‑assurance packaging and active barrier solutions for the cold‑chain market.
   Sonoco’s latest offering is a blister pack that couples a desiccant sachet with a TTI, providing visual confirmation of temperature excursions for biologics shipped to remote sites.
   Sustainability Initiative: Sonoco is investing in renewable energy for its manufacturing sites and has launched a program to recycle post‑consumer packaging from the pharmaceutical sector.
   Highlights:

   • Extensive distribution network across North America
   • Partnerships with pharmaceutical supply‑chain service providers
   • Robust R&D in moisture‑control technologies

6. West Pharmaceutical Services, Inc. – United States
   Key Offering: Containment and delivery systems for injectable drugs, incorporating intelligent features.
   West Pharma’s recent innovation is a syringe sleeve that integrates a RFID tag and a temperature sensor, enabling real‑time monitoring of biologic injectables during transport.
   Sustainability Initiative: The company is working to reduce packaging waste by 20 % through design optimization and material substitution.
   Highlights:

   • Strong presence in the injectable segment
   • Collaborations with major vaccine manufacturers
   • Investment in IoT‑enabled packaging solutions

7. Tekni‑Plex, Inc. – United States
   Key Offering: Specialty films and tubing used in pharmaceutical active packaging.
   Tekni‑Plex’s new line of high‑barrier films incorporates active agents that neutralize oxygen and moisture, extending the shelf life of solid oral dosage forms.
   Sustainability Initiative: The company is reducing its water consumption by 15 % per unit of production and is developing recyclable film blends.
   Highlights:

   • Dedicated manufacturing facilities in the U.S. and Europe
   • Advanced coating technologies for blister packs
   • Strategic alliances with contract manufacturers

8. Constantia Flexibles – Austria
   Key Offering: High‑barrier flexible packaging films with active properties.
   Constantia Flexibles has introduced a line of multi‑layer films that embed antimicrobial agents and humidity‑control layers, targeting the oral and injectable markets.
   Sustainability Initiative: The firm is focusing on reducing its energy usage in film production and has set a target to achieve 100 % renewable electricity by 2030.
   Highlights:

   • Strong presence in the European market
   • Partnerships with leading pharmaceutical companies for secondary packaging
   • Investment in smart label integration

9. CCL Industries – Canada
   Key Offering: Intelligent labels incorporating RFID and NFC technologies.
   CCL’s recent launch of a QR‑code‑enabled blister pack that communicates real‑time temperature data to pharmacies enhances traceability and compliance with regulatory mandates.
   Sustainability Initiative: The company is developing biodegradable label substrates to reduce plastic waste in packaging.
   Highlights:

   • Strong foothold in the North American market
   • Collaborations with logistics and distribution partners
   • Focus on anti‑counterfeiting solutions

10. Honeywell International Inc. – United States
    Key Offering: Specialty barrier films and smart sensor components for pharmaceutical intelligent packaging.
    Honeywell’s latest sensor suite can detect temperature, humidity, and vibration, providing comprehensive data for high‑value biologics during transport.
    Sustainability Initiative: The company is investing in circular supply chains and aims to eliminate single‑use plastics from its packaging line by 2035.
    Highlights:

    • Global R&D network focused on sensor technology
    • Partnerships with major pharmaceutical manufacturers
    • Robust portfolio of barrier films

Pharmaceutical Active and Intelligent Packaging Market – View in Detailed Research Report

Pharmaceutical Active and Intelligent Packaging Market – View in Detailed Research Report

Outlook

The trajectory of the pharmaceutical active and intelligent packaging market is shaped by an evolving regulatory landscape that increasingly mandates serialization, tamper‑evident features, and real‑time monitoring. As biologics and biosimilars continue to dominate the drug pipeline, the demand for packaging that can safeguard product integrity from manufacture to patient will intensify. Companies that combine active barrier technologies with intelligent monitoring are positioned to capture the largest share of the market, especially in high‑growth regions such as Asia‑Pacific and North America.

Future Trends

1. Integration of IoT and AI – Connected packaging systems will provide predictive analytics for cold‑chain management, enabling proactive interventions before temperature excursions occur.
2. Patient‑centric Packaging – Smart blister packs that link dosage data to mobile applications will improve medication adherence and support remote patient monitoring.
3. Sustainability Focus – The industry will accelerate the adoption of recyclable and biodegradable materials, driven by regulatory incentives and consumer demand for eco‑friendly solutions.
4. Advanced Anti‑Counterfeiting – The convergence of RFID, NFC, and holographic security features will create robust authentication mechanisms across global supply chains.